Lloyd Mulenga, PhD, MMed, MBChB, MSc is an Infectious Disease and Internal Medicine Specialist, practicing at the University Teaching Hospital, in Lusaka, Zambia and the Director of Infectious Diseases for the Ministry of Health. He is the lead infectious diseases physician for the Zambian COVID-19 clinical response. He currently serves on the United States National Institute of Health (NIH) Data and Safety Monitoring Boards for the Division of AIDS National Institute of Allergy and Infectious Diseases (NIAID), the WHO Guidelines Development Group and the WHO HIV Drug Resistance Network (HIVResNet). His research focuses on HIV and clinical outcomes and drug resistance, HIV and non-communicable diseases (kidney, cardiovascular and diabetes) and infectious diseases epidemiology and clinical outcomes including SARS-CoV-2, tuberculosis and hepatitis.
As a physician-scientist-policymaker, Dr. Mulenga leads infectious disease activities at the University of Zambia, in the university’s teaching hospital and lab, as well as within his country’s health ministry. In addition to conducting research and publishing in nearly 50 journals, he also has engaged in science diplomacy, delivered a plenary presentation on the state of HIV in Africa at the U.N., and participated in a WHO review of the agency’s HIV treatment guidelines.
Dr. Mulenga earned his PhD through the Fogarty-supported University of Zambia-Vanderbilt Training Partnership for HIV-Nutrition-Metabolic Research and completed his medical education at the Univeristy of Zambia.